{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:38:08Z","timestamp":1707525488208},"reference-count":71,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,3]]},"DOI":"10.7759\/cureus.49870","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T16:22:11Z","timestamp":1701620531000},"source":"Crossref","is-referenced-by-count":0,"title":["Navigating the Landscape of Hydrocortisone Administration in Septic Shock: Current Concepts and Future Directions"],"prefix":"10.7759","author":[{"given":"Anirudh","family":"Kommareddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayant D","family":"Vagha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revat J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss RS","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016, 2:16045. 10.1038\/nrdp.2016.45","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","unstructured":"Sepsis. Accessed. September 7, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sepsis."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.04.120","article-title":"Hydrocortisone in septic shock: all the questions answered?","volume":"10","author":"Briegel J","year":"2018","unstructured":"Briegel J, Huge V, M\u00f6hnle P. Hydrocortisone in septic shock: all the questions answered?. J Thorac Dis. 2018, 10:S1962-5. 10.21037\/jtd.2018.04.120","journal-title":"J Thorac Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.906208","article-title":"Effects of hydrocortisone on regulating inflammation, hemodynamic stability, and preventing shock in severe sepsis patients","volume":"24","author":"Zhao Y","year":"2018","unstructured":"Zhao Y, Ding C. Effects of hydrocortisone on regulating inflammation, hemodynamic stability, and preventing shock in severe sepsis patients. Med Sci Monit. 2018, 24:3612-9. 10.12659\/MSM.906208","journal-title":"Med Sci Monit"},{"key":"ref6","article-title":"Systemic inflammatory response syndrome","author":"Chakraborty RK","year":"2023","unstructured":"Chakraborty RK, Burns B. Systemic inflammatory response syndrome. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm-definition, causes, and implications","volume":"23","author":"Jarczak D","year":"2022","unstructured":"Jarczak D, Nierhaus A. Cytokine storm-definition, causes, and implications. Int J Mol Sci. 2022, 23:10.3390\/ijms231911740","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20130597","article-title":"Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation","volume":"94","author":"Hannibal KE","year":"2014","unstructured":"Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther. 2014, 94:1816-25. 10.2522\/ptj.20130597","journal-title":"Phys Ther"},{"key":"ref9","article-title":"Physiology, cortisol","author":"Thau L","year":"2023","unstructured":"Thau L, Gandhi J, Sharma S. Physiology, cortisol. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00284","article-title":"Sympathetic regulation of vascular function in health and disease","volume":"3","author":"Bruno RM","year":"2012","unstructured":"Bruno RM, Ghiadoni L, Seravalle G, Dell'oro R, Taddei S, Grassi G. Sympathetic regulation of vascular function in health and disease. Front Physiol. 2012, 3:284. 10.3389\/fphys.2012.00284","journal-title":"Front Physiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.47176\/mjiri.35.154","article-title":"Adrenal insufficiency in septic patients admitted to intensive care unit: prevalence and associated factors","volume":"35","author":"Hashemi-Madani N","year":"2021","unstructured":"Hashemi-Madani N, Miri M, Emami Z, Barati M, Golgiri F. Adrenal insufficiency in septic patients admitted to intensive care unit: prevalence and associated factors. Med J Islam Repub Iran. 2021, 35:154. 10.47176\/mjiri.35.154","journal-title":"Med J Islam Repub Iran"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071801","article-title":"Changes in cortisol secretion and corticosteroid receptors in covid-19 and non covid-19 critically ill patients with sepsis\/septic shock and scope for treatment","volume":"11","author":"Ilias I","year":"2023","unstructured":"Ilias I, Vassiliou AG, Keskinidou C, Vrettou CS, Orfanos S, Kotanidou A, Dimopoulou I. Changes in cortisol secretion and corticosteroid receptors in covid-19 and non covid-19 critically ill patients with sepsis\/septic shock and scope for treatment. Biomedicines. 2023, 11:1801. 10.3390\/biomedicines11071801","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1659-4","article-title":"Corticosteroids in septic shock: a systematic review and network meta-analysis","volume":"21","author":"Gibbison B","year":"2017","unstructured":"Gibbison B, L\u00f3pez-L\u00f3pez JA, Higgins JP, Miller T, Angelini GD, Lightman SL, Annane D. Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care. 2017, 21:78. 10.1186\/s13054-017-1659-4","journal-title":"Crit Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199507000-00021","article-title":"Steroid controversy in sepsis and septic shock: a meta-analysis","volume":"23","author":"Lefering R","year":"1995","unstructured":"Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995, 23:1294-303. 10.1097\/00003246-199507000-00021","journal-title":"Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0972-5229.58539","article-title":"Role of steroids in septic shock: assessment of knowledge, attitudes and practices among intensivists practising in Hyderabad","volume":"13","author":"Juneja D","year":"2009","unstructured":"Juneja D, Gopal PB, Satapathy RR, Raya R, Madgundi VV. Role of steroids in septic shock: assessment of knowledge, attitudes and practices among intensivists practising in Hyderabad. Indian J Crit Care Med. 2009, 13:143-7. 10.4103\/0972-5229.58539","journal-title":"Indian J Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4914","article-title":"Hydrocortisone reduces 28-day mortality in septic patients: a systemic review and meta-analysis","volume":"11","author":"Siddiqui WJ","year":"2019","unstructured":"Siddiqui WJ, Iyer P, Aftab G, et al.. Hydrocortisone reduces 28-day mortality in septic patients: a systemic review and meta-analysis. Cureus. 2019, 11:e4914. 10.7759\/cureus.4914","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ija.IJA_142_19","article-title":"Publication bias - importance of studies with negative results!","volume":"63","author":"Nair AS","year":"2019","unstructured":"Nair AS. Publication bias - importance of studies with negative results!. Indian J Anaesth. 2019, 63:505-7. 10.4103\/ija.IJA_142_19","journal-title":"Indian J Anaesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119835043","article-title":"Sepsis: the evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali B","year":"2019","unstructured":"Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: the evolution in definition, pathophysiology, and management. SAGE Open Med. 2019, 7:2050312119835043. 10.1177\/2050312119835043","journal-title":"SAGE Open Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the Hypress randomized clinical trial","volume":"316","author":"Keh D","year":"2016","unstructured":"Keh D, Trips E, Marx G, et al.. Effect of hydrocortisone on development of shock among patients with severe sepsis: the Hypress randomized clinical trial. JAMA. 2016, 316:1775-85. 10.1001\/jama.2016.14799","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh B","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, et al.. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018, 378:797-808. 10.1056\/NEJMoa1705835","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.563","article-title":"Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta-analysis","volume":"7","author":"Yamamoto R","year":"2020","unstructured":"Yamamoto R, Nahara I, Toyosaki M, Fukuda T, Masuda Y, Fujishima S. Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta-analysis. Acute Med Surg. 2020, 7:e563. 10.1002\/ams2.563","journal-title":"Acute Med Surg"},{"key":"ref22","article-title":"Impact on efficacy and safety of hydrocortisone in sepsis and septic shock - a systematic literature review and meta-analysis","volume":"22","author":"Aletreby WT","year":"2019","unstructured":"Aletreby WT, Alharthy AM, Madi AF, et al.. Impact on efficacy and safety of hydrocortisone in sepsis and septic shock - a systematic literature review and meta-analysis. Arch Iran Med. 2019, 22:394-402.","journal-title":"Arch Iran Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas J","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, et al.. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014, 24:1670. 10.1089\/thy.2014.0028","journal-title":"Thyroid"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181d4f34d","article-title":"Hydrocortisone supplementation enhances hemodynamic stability in brain-dead patients","volume":"112","author":"Nicolas-Robin A","year":"2010","unstructured":"Nicolas-Robin A, Barouk JD, Amour J, Coriat P, Riou B, Langeron O. Hydrocortisone supplementation enhances hemodynamic stability in brain-dead patients. Anesthesiology. 2010, 112:1204-10. 10.1097\/ALN.0b013e3181d4f34d","journal-title":"Anesthesiology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.04.24","article-title":"Vasopressors in septic shock: which, when, and how much?","volume":"8","author":"Shi R","year":"2020","unstructured":"Shi R, Hamzaoui O, De Vita N, Monnet X, Teboul JL. Vasopressors in septic shock: which, when, and how much?. Ann Transl Med. 2020, 8:794. 10.21037\/atm.2020.04.24","journal-title":"Ann Transl Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-258","article-title":"Adrenal insufficiency - recognition and management","volume":"17","author":"Pazderska A","year":"2017","unstructured":"Pazderska A, Pearce SH. Adrenal insufficiency - recognition and management. Clin Med (Lond). 2017, 17:258-62. 10.7861\/clinmedicine.17-3-258","journal-title":"Clin Med (Lond)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002243.pub4","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"12","author":"Annane D","year":"2019","unstructured":"Annane D, Bellissant E, Bollaert PE, et al.. Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev. 2019, 12:CD002243. 10.1002\/14651858.CD002243.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1559821","article-title":"Relative adrenal insufficiency in pediatric septic shock","volume":"4","author":"Vila-P\u00e9rez D","year":"2015","unstructured":"Vila-P\u00e9rez D, Jordan-Garc\u00eda I. Relative adrenal insufficiency in pediatric septic shock. J Pediatr Intensive Care. 2015, 4:129-37. 10.1055\/s-0035-1559821","journal-title":"J Pediatr Intensive Care"},{"key":"ref29","article-title":"Adrenocorticotropic hormone test","author":"Khare S","year":"2023","unstructured":"Khare S, Anjum F. Adrenocorticotropic hormone test. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00091","article-title":"Biomarkers in stress related diseases\/disorders: diagnostic, prognostic, and therapeutic values","volume":"6","author":"Dhama K","year":"2019","unstructured":"Dhama K, Latheef SK, Dadar M, et al.. Biomarkers in stress related diseases\/disorders: diagnostic, prognostic, and therapeutic values. Front Mol Biosci. 2019, 6:91. 10.3389\/fmolb.2019.00091","journal-title":"Front Mol Biosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111762","article-title":"Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid","volume":"10","author":"Marik PE","year":"2018","unstructured":"Marik PE. Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid. Nutrients. 2018, 10:10.3390\/nu10111762","journal-title":"Nutrients"},{"key":"ref32","article-title":"Refractory shock","author":"Barola S","year":"2023","unstructured":"Barola S, Shabbir N. Refractory shock. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2174\/1871529x15666150108114810","article-title":"Sepsis pathophysiology and anesthetic consideration","volume":"15","author":"Yuki K","year":"2015","unstructured":"Yuki K, Murakami N. Sepsis pathophysiology and anesthetic consideration. Cardiovasc Hematol Disord Drug Targets. 2015, 15:57-69. 10.2174\/1871529x15666150108114810","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref34","article-title":"Evaluation of hydrocortisone continuous infusion versus intermittent boluses in resolution of septic shock","volume":"42","author":"Hoang H","year":"2017","unstructured":"Hoang H, Wang S, Islam S, Hanna A, Axelrad A, Brathwaite C. Evaluation of hydrocortisone continuous infusion versus intermittent boluses in resolution of septic shock. P T. 2017, 42:252-5.","journal-title":"P T"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-016-3865-7","article-title":"Strategies for intravenous fluid resuscitation in trauma patients","volume":"41","author":"Wise R","year":"2017","unstructured":"Wise R, Faurie M, Malbrain ML, Hodgson E. Strategies for intravenous fluid resuscitation in trauma patients. World J Surg. 2017, 41:1170-83. 10.1007\/s00268-016-3865-7","journal-title":"World J Surg"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein SR","year":"2015","unstructured":"Bornstein SR, Allolio B, Arlt W, et al.. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015, 101:364-89. 10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"ref37","article-title":"Corticosteroid adverse effects","author":"Yasir M","year":"2023","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.4103\/2229-3485.71839","article-title":"Evolution of clinical research: a history before and beyond james lind","volume":"1","author":"Bhatt A","year":"2010","unstructured":"Bhatt A. Evolution of clinical research: a history before and beyond james lind. Perspect Clin Res. 2010, 1:6-10.","journal-title":"Perspect Clin Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection risk and safety of corticosteroid use","volume":"42","author":"Youssef J","year":"2016","unstructured":"Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016, 42:157-76, ix-x. 10.1016\/j.rdc.2015.08.004","journal-title":"Rheum Dis Clin North Am"},{"key":"ref40","article-title":"Adrenal Crisis","author":"Elshimy G","year":"2023","unstructured":"Elshimy G, Chippa V, Jeong JM. Adrenal Crisis. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i8.1073","article-title":"Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: a narrative review","volume":"6","author":"Tamez-P\u00e9rez HE","year":"2015","unstructured":"Tamez-P\u00e9rez HE, Quintanilla-Flores DL, Rodr\u00edguez-Guti\u00e9rrez R, Gonz\u00e1lez-Gonz\u00e1lez JG, Tamez-Pe\u00f1a AL. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015, 6:1073-81. 10.4239\/wjd.v6.i8.1073","journal-title":"World J Diabetes"},{"key":"ref42","article-title":"Management of diabetes and hyperglycemia in hospitalized patients","author":"Dhatariya K","year":"2000","unstructured":"Dhatariya K, Corsino L, Umpierrez GE. Management of diabetes and hyperglycemia in hospitalized patients. In: Endotext [Internet]. MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.120975","article-title":"Corticosteroid-related central nervous system side effects","volume":"4","author":"Ciriaco M","year":"2013","unstructured":"Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013, 4:S94-8. 10.4103\/0976-500X.120975","journal-title":"J Pharmacol Pharmacother"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: american society of clinical oncology clinical practice guideline","volume":"36","author":"Brahmer JR","year":"2018","unstructured":"Brahmer JR, Lacchetti C, Schneider BJ, et al.. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2018, 36:1714-68. 10.1200\/JCO.2017.77.6385","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view","volume":"2013","author":"Schulte W","year":"2013","unstructured":"Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view. Mediators Inflamm. 2013, 2013:165974. 10.1155\/2013\/165974","journal-title":"Mediators Inflamm"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra T","year":"2003","unstructured":"Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003, 3:791-800. 10.1038\/nri1200","journal-title":"Nat Rev Immunol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2174\/156802607779941314","article-title":"Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers","volume":"7","author":"Khanapure SP","year":"2007","unstructured":"Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007, 7:311-40. 10.2174\/156802607779941314","journal-title":"Curr Top Med Chem"},{"key":"ref48","article-title":"Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications (Article in German)","volume":"114 Suppl 1","author":"Briegel J","year":"2002","unstructured":"Briegel J. Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications (Article in German). Wien Klin Wochenschr. 2002, 114 Suppl 1:9-19.","journal-title":"Wien Klin Wochenschr"},{"key":"ref49","article-title":"Inotropes and vasopressors","author":"VanValkinburgh D","year":"2023","unstructured":"VanValkinburgh D, Kerndt CC, Hashmi MF. Inotropes and vasopressors. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref50","article-title":"Physiology, vasodilation","author":"Ramanlal R","year":"2023","unstructured":"Ramanlal R, Gupta V. Physiology, vasodilation. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-1-27","article-title":"Microcirculatory alterations: potential mechanisms and implications for therapy","volume":"1","author":"De Backer D","year":"2011","unstructured":"De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care. 2011, 1:27. 10.1186\/2110-5820-1-27","journal-title":"Ann Intensive Care"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/1751143716678638","article-title":"The microcirculation and its measurement in sepsis","volume":"18","author":"Charlton M","year":"2017","unstructured":"Charlton M, Sims M, Coats T, Thompson JP. The microcirculation and its measurement in sepsis. J Intensive Care Soc. 2017, 18:221-7. 10.1177\/1751143716678638","journal-title":"J Intensive Care Soc"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho AE","year":"2011","unstructured":"Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011, 335:2-13. 10.1016\/j.mce.2010.04.005","journal-title":"Mol Cell Endocrinol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.130.4.601","article-title":"Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry","volume":"130","author":"Segerstrom SC","year":"2004","unstructured":"Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004, 130:601-30. 10.1037\/0033-2909.130.4.601","journal-title":"Psychol Bull"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-1-7","article-title":"Corticosteroids for severe sepsis: an evidence-based guide for physicians","volume":"1","author":"Annane D","year":"2011","unstructured":"Annane D. Corticosteroids for severe sepsis: an evidence-based guide for physicians. Ann Intensive Care. 2011, 1:7. 10.1186\/2110-5820-1-7","journal-title":"Ann Intensive Care"},{"key":"ref56","article-title":"The adaptive immune system","author":"Alberts B","year":"2002","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. The adaptive immune system. In: Molecular Biology of the Cell (4th edition). Garland Science, New York; 2002."},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin DD","year":"2010","unstructured":"Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010, 125:S3-23. 10.1016\/j.jaci.2009.12.980","journal-title":"J Allergy Clin Immunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/10253890.2018.1470238","article-title":"Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility","volume":"21","author":"Gjerstad JK","year":"2018","unstructured":"Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018, 21:403-16. 10.1080\/10253890.2018.1470238","journal-title":"Stress"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2005.18.3.295","article-title":"Disturbed adrenal function in adolescents with chronic fatigue syndrome","volume":"18","author":"Segal TY","year":"2005","unstructured":"Segal TY, Hindmarsh PC, Viner RM. Disturbed adrenal function in adolescents with chronic fatigue syndrome. J Pediatr Endocrinol Metab. 2005, 18:295-302. 10.1515\/jpem.2005.18.3.295","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref60","article-title":"Glucocorticoid therapy and adrenal suppression","author":"Nicolaides NC","year":"2000","unstructured":"Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP. Glucocorticoid therapy and adrenal suppression. In: Endotext [Internet]. Feingold KR, Anawalt B, Blackman MR, et al (ed): MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2017.10.01","article-title":"Recovery of steroid induced adrenal insufficiency","volume":"6","author":"Younes AK","year":"2017","unstructured":"Younes AK, Younes NK. Recovery of steroid induced adrenal insufficiency. Transl Pediatr. 2017, 6:269-73. 10.21037\/tp.2017.10.01","journal-title":"Transl Pediatr"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch NA","year":"2023","unstructured":"Bosch NA, Teja B, Law AC, Pang B, Jafarzadeh SR, Walkey AJ. Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock. JAMA Intern Med. 2023, 183:451-9. 10.1001\/jamainternmed.2023.0258","journal-title":"JAMA Intern Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136764","article-title":"Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?","volume":"22","author":"Kino T","year":"2021","unstructured":"Kino T, Burd I, Segars JH. Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?. Int J Mol Sci. 2021, 22:10.3390\/ijms22136764","journal-title":"Int J Mol Sci"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i9.1095","article-title":"Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease","volume":"17","author":"De Iudicibus S","year":"2011","unstructured":"De Iudicibus S, Franca R, Martelossi S, Ventura A, Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol. 2011, 17:1095-108. 10.3748\/wjg.v17.i9.1095","journal-title":"World J Gastroenterol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000116","article-title":"Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases","volume":"2020","author":"Malpica L","year":"2020","unstructured":"Malpica L, Moll S. Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases. Hematology. 2020, 2020:319-27. 10.1182\/hematology.2020000116","journal-title":"Hematology"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-7-13","article-title":"Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy","volume":"7","author":"Ahmet A","year":"2011","unstructured":"Ahmet A, Kim H, Spier S. Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol. 2011, 7:13. 10.1186\/1710-1492-7-13","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v03n0104","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown ES","year":"2001","unstructured":"Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001, 3:17-21. 10.4088\/pcc.v03n0104","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002737","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"45","author":"Annane D","year":"2017","unstructured":"Annane D, Pastores SM, Rochwerg B, et al.. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017, 45:2078-88. 10.1097\/CCM.0000000000002737","journal-title":"Crit Care Med"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa059","article-title":"Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure","volume":"72","author":"Rhee C","year":"2021","unstructured":"Rhee C, Chiotos K, Cosgrove SE, et al.. Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure. Clin Infect Dis. 2021, 72:541-52. 10.1093\/cid\/ciaa059","journal-title":"Clin Infect Dis"},{"key":"ref71","article-title":"Clinical Practice Guidelines as a quality strategy","author":"Panteli D","year":"2019","unstructured":"Panteli D, Legido-Quigley H, Reichebner C, Ollenschl\u00e4ger G, Sch\u00e4fer C, Busse R. Clinical Practice Guidelines as a quality strategy. In: Improving healthcare quality in Europe: characteristics, effectiveness and implementation of different strategies. Busse R, Klazinga N, Panteli D, et al (ed): European Observatory on Health Systems and Policies, Copenhagen (Denmark); 2019."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/190128-navigating-the-landscape-of-hydrocortisone-administration-in-septic-shock-current-concepts-and-future-directions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:38Z","timestamp":1707509498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/190128-navigating-the-landscape-of-hydrocortisone-administration-in-septic-shock-current-concepts-and-future-directions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,3]]},"references-count":71,"URL":"https:\/\/doi.org\/10.7759\/cureus.49870","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,3]]}}}